DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-6 is/are rejected under 35 U.S.C. 102(a1) as being anticipated by Shekalim et al (US 2020/0376204 A1).
As to claim 1, Shekalim et al disclose an injection device comprising: an injector body (200); a cartridge (210) coupled to the injector body and having a first height (210 extends along the length of 200, figure 1) and comprising an orifice (230); and a cap (100) coupled to the injector body having a second height (figure 1) and comprising an outer rim (figure 7A), wherein the outer rim surrounds the cartridge (figure 7A), and wherein the first height is greater than the second height (figure 1).
As to claim 2, Shekalim et al disclose the injection device of claim 1, wherein the outer rim of the cap comprises a pressure sensor (132).
As to claim 3, Shekalim et al disclose the injection device of claim 2, wherein the cap further comprises a trigger button (131) configured to activate when the pressure sensor detects a minimum threshold of pressure.
As to claim 4, Shekalim et al disclose the injection device of claim 1, wherein the cartridge comprises a pressure sensor (115, Figure 12).
As to claim 5, Shekalim et al disclose the injection device of claim 4, wherein the cap further comprises a trigger button (131) configured to activate when the pressure sensor detects a minimum threshold of pressure.
As to claim 6, Shekalim et al disclose the injection device of claim 1, further comprising a spring (154) coupled to the cartridge configured to eject medicine from the vial upon release of the spring.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to IMANI N HAYMAN whose telephone number is (571)270-5528. The examiner can normally be reached 5:30 AM - 3:30 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/IMANI N HAYMAN/Supervisory Patent Examiner, Art Unit 2841